...
机译:在健康日本科目中的氟辛呋盐和类化合物组合的安全性,药代动力学和药效学
Clinical Pharmacology Department Development and Medical Affairs Division 6-15 Sendagaya 4-chome;
Clinical Pharmacology Department Development and Medical Affairs Division 6-15 Sendagaya 4-chome;
Clinical Pharmacology Modeling and Simulation Respiratory Medicine Development Centre;
Clinical Pharmacology Modeling and Simulation Respiratory Medicine Development Centre;
Clinical Research Department 4 Development and Medical Affairs Division GlaxoSmithKline Tokyo;
Clinical Pharmacology Department Development and Medical Affairs Division 6-15 Sendagaya 4-chome;
Clinical Pharmacology Department Development and Medical Affairs Division 6-15 Sendagaya 4-chome;
Fluticasone furoate; Pharmacodynamics; Pharmacokinetics; Safety; Tolerability; Vilanterol;
机译:在健康日本科目中的氟辛呋盐和类化合物组合的安全性,药代动力学和药效学
机译:酮康唑对吸入性糠酸氟替卡松和三氟维那特罗的药代动力学和药效学的影响
机译:酮康唑对吸入氟替卡松糠酸酯和维那特罗三氟萘酸酯在健康受试者中的药代动力学和药效学的影响
机译:在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性,耐受性,药效动力学和药代动力学
机译:阿法曲巴帕在健康受试者和慢性肝病患者中的药代动力学/药效学分析
机译:酮康唑对吸入性糠酸氟替卡松和三氟维那特罗的药代动力学和药效学的影响
机译:有效性和安全性比较:氟替卡松糠酸酯和丙酸氟替卡松,在日本哮喘控制良好的患者中从氟替卡松/维兰特罗卸任后,一项随机试验